Stranded Technologies Podcast cover image

Ep. 99: A Conversation with Cremieux - How to Tell Good Science from Junk, and What’s Next in US Biotech & Deregulation

Stranded Technologies Podcast

00:00

Arbitraging stuck approvals and novel indications

Cremieux suggests pursuing repurposing and new indications (e.g., GLP-1s) where evidence can be produced faster and cheaper.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app